This infographic, curated by our Beacon Bispecific experts, reviews:
- The year-on-year growth in the number of bispecific combination trials
- Invaluable data on trial status and phase distribution
- The potential of various combination strategies, including small molecule, biological therapy and double bispecific combinations
To learn more about this infographic, or how Beacon Bispecific can enhance your data needs and provide fast insights, please book a research session below or contact us directly on beacon@hansonwade.com.
Speak with our team of experts
Our dedicated account and research teams are on hand to showcase how Beacon can help you find the answers to your bispecific-related questions
About Beacon
Beacon is the essential decision-support tool for developers of complex therapeutics. Our market-defining, proprietary ontologies, combined with the most accurate and comprehensive life sciences data, provide our customers with unparalleled visibility of the drug and trial landscape.
With Beacon, you can make drug development decisions with confidence. This is why 23 of the world’s top 25 drug developers trust us.
